Species differences in phenazeram kinetics and metabolism

V. P. Zherdev, S. Caccia, S. Garattini, A. L. Ekonomov

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The kinetic profiles of phenazepam and its hydroxylated derivative were compared in rat, dog, cat and man after administration of single oral doses of the parent compound. The absorption of phenazepam was reasonably rapid in all the species studied. Blood peak concentrations (Cmax) were reached at 1 h in rats (0.32 ± 0.03 μg/ml), at 0.5 h in dogs 0.54 ± 0.10 μg/ml), at about 2 h in cats (1.65 ±0.23 μg/ml), abut only at 4 h in man (0.038 μg/ml) at the highest dose tested. The largest normalized (value/dose) Cmax and area under the curve (AUC) were observed in man, while the rat gave the lowest values. The half-life of phenazepam was about 60 h in man, 13.72 ± 2.09 h in the cat, 6.35 ± 2.32 h in the dog and 7.49 ± 1.88 h in the rat (β-half-life). 3-OH-phenazepam was rapidly detected in cat, rat, and dog blood but no measurable amounts (<3 ng/ml) were found in human blood. At the oral doses tested, the ratio of the AUC for 3-OH-phenazepam to phenazepam was 0.01, 0.48, and 0.53 in the dog, rat, and cat, respectively. The half-life of the metabolite was shorter than that of the parent compound in the dog, but it was comparable in the rat and longer in the cat. The results suggest that 3-OH- phenazepam might contribute to the overall pharmacological effects of the parent compound in those species in which it accumulates in significant amounts.

Original languageEnglish
Pages (from-to)191-196
Number of pages6
JournalEuropean Journal of Drug Metabolism and Pharmacokinetics
Volume7
Issue number3
DOIs
Publication statusPublished - Jul 1982

Fingerprint

Cats
Dogs
Half-Life
Area Under Curve
phenazepam
Oral Administration
Pharmacology
hydroxide ion

Keywords

  • 3-OH-phenazepam
  • animals
  • azepam
  • kinetics
  • man

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Species differences in phenazeram kinetics and metabolism. / Zherdev, V. P.; Caccia, S.; Garattini, S.; Ekonomov, A. L.

In: European Journal of Drug Metabolism and Pharmacokinetics, Vol. 7, No. 3, 07.1982, p. 191-196.

Research output: Contribution to journalArticle

Zherdev, V. P. ; Caccia, S. ; Garattini, S. ; Ekonomov, A. L. / Species differences in phenazeram kinetics and metabolism. In: European Journal of Drug Metabolism and Pharmacokinetics. 1982 ; Vol. 7, No. 3. pp. 191-196.
@article{16be72d3d89d4852b055eec00ebf7569,
title = "Species differences in phenazeram kinetics and metabolism",
abstract = "The kinetic profiles of phenazepam and its hydroxylated derivative were compared in rat, dog, cat and man after administration of single oral doses of the parent compound. The absorption of phenazepam was reasonably rapid in all the species studied. Blood peak concentrations (Cmax) were reached at 1 h in rats (0.32 ± 0.03 μg/ml), at 0.5 h in dogs 0.54 ± 0.10 μg/ml), at about 2 h in cats (1.65 ±0.23 μg/ml), abut only at 4 h in man (0.038 μg/ml) at the highest dose tested. The largest normalized (value/dose) Cmax and area under the curve (AUC) were observed in man, while the rat gave the lowest values. The half-life of phenazepam was about 60 h in man, 13.72 ± 2.09 h in the cat, 6.35 ± 2.32 h in the dog and 7.49 ± 1.88 h in the rat (β-half-life). 3-OH-phenazepam was rapidly detected in cat, rat, and dog blood but no measurable amounts (<3 ng/ml) were found in human blood. At the oral doses tested, the ratio of the AUC for 3-OH-phenazepam to phenazepam was 0.01, 0.48, and 0.53 in the dog, rat, and cat, respectively. The half-life of the metabolite was shorter than that of the parent compound in the dog, but it was comparable in the rat and longer in the cat. The results suggest that 3-OH- phenazepam might contribute to the overall pharmacological effects of the parent compound in those species in which it accumulates in significant amounts.",
keywords = "3-OH-phenazepam, animals, azepam, kinetics, man",
author = "Zherdev, {V. P.} and S. Caccia and S. Garattini and Ekonomov, {A. L.}",
year = "1982",
month = "7",
doi = "10.1007/BF03189565",
language = "English",
volume = "7",
pages = "191--196",
journal = "European Journal of Drug Metabolism and Pharmacokinetics",
issn = "0378-7966",
publisher = "Springer Paris",
number = "3",

}

TY - JOUR

T1 - Species differences in phenazeram kinetics and metabolism

AU - Zherdev, V. P.

AU - Caccia, S.

AU - Garattini, S.

AU - Ekonomov, A. L.

PY - 1982/7

Y1 - 1982/7

N2 - The kinetic profiles of phenazepam and its hydroxylated derivative were compared in rat, dog, cat and man after administration of single oral doses of the parent compound. The absorption of phenazepam was reasonably rapid in all the species studied. Blood peak concentrations (Cmax) were reached at 1 h in rats (0.32 ± 0.03 μg/ml), at 0.5 h in dogs 0.54 ± 0.10 μg/ml), at about 2 h in cats (1.65 ±0.23 μg/ml), abut only at 4 h in man (0.038 μg/ml) at the highest dose tested. The largest normalized (value/dose) Cmax and area under the curve (AUC) were observed in man, while the rat gave the lowest values. The half-life of phenazepam was about 60 h in man, 13.72 ± 2.09 h in the cat, 6.35 ± 2.32 h in the dog and 7.49 ± 1.88 h in the rat (β-half-life). 3-OH-phenazepam was rapidly detected in cat, rat, and dog blood but no measurable amounts (<3 ng/ml) were found in human blood. At the oral doses tested, the ratio of the AUC for 3-OH-phenazepam to phenazepam was 0.01, 0.48, and 0.53 in the dog, rat, and cat, respectively. The half-life of the metabolite was shorter than that of the parent compound in the dog, but it was comparable in the rat and longer in the cat. The results suggest that 3-OH- phenazepam might contribute to the overall pharmacological effects of the parent compound in those species in which it accumulates in significant amounts.

AB - The kinetic profiles of phenazepam and its hydroxylated derivative were compared in rat, dog, cat and man after administration of single oral doses of the parent compound. The absorption of phenazepam was reasonably rapid in all the species studied. Blood peak concentrations (Cmax) were reached at 1 h in rats (0.32 ± 0.03 μg/ml), at 0.5 h in dogs 0.54 ± 0.10 μg/ml), at about 2 h in cats (1.65 ±0.23 μg/ml), abut only at 4 h in man (0.038 μg/ml) at the highest dose tested. The largest normalized (value/dose) Cmax and area under the curve (AUC) were observed in man, while the rat gave the lowest values. The half-life of phenazepam was about 60 h in man, 13.72 ± 2.09 h in the cat, 6.35 ± 2.32 h in the dog and 7.49 ± 1.88 h in the rat (β-half-life). 3-OH-phenazepam was rapidly detected in cat, rat, and dog blood but no measurable amounts (<3 ng/ml) were found in human blood. At the oral doses tested, the ratio of the AUC for 3-OH-phenazepam to phenazepam was 0.01, 0.48, and 0.53 in the dog, rat, and cat, respectively. The half-life of the metabolite was shorter than that of the parent compound in the dog, but it was comparable in the rat and longer in the cat. The results suggest that 3-OH- phenazepam might contribute to the overall pharmacological effects of the parent compound in those species in which it accumulates in significant amounts.

KW - 3-OH-phenazepam

KW - animals

KW - azepam

KW - kinetics

KW - man

UR - http://www.scopus.com/inward/record.url?scp=0019937092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019937092&partnerID=8YFLogxK

U2 - 10.1007/BF03189565

DO - 10.1007/BF03189565

M3 - Article

C2 - 7173273

AN - SCOPUS:0019937092

VL - 7

SP - 191

EP - 196

JO - European Journal of Drug Metabolism and Pharmacokinetics

JF - European Journal of Drug Metabolism and Pharmacokinetics

SN - 0378-7966

IS - 3

ER -